Nestlé Wins EU Nod for Water Venture as JPMorgan Turns Bullish and Texas Lawsuit Lands
Published on 10/16/2026 at 16:31 | Editorial boerse-global.de
Nestlé shares are riding an eight-session winning streak into its next earnings report, but the flow of news around the Swiss food giant is anything but one-directional. A green light from Brussels for a major water deal and a broker upgrade on one side are being offset by fresh legal action in the United States on the other, leaving investors to weigh regulatory progress against unresolved risk.
The stock added 2.5% on Wednesday, extending a run of consecutive gains. Media reports have pointed to the European Commission's approval of the planned Peranel joint venture as a possible backdrop for the rally, though the timing alone does not establish it as the driver.
Brussels Clears Peranel, but Closing Lies Ahead
On Tuesday, the EU Commission authorised the water joint venture between Nestlé and Platinum Equity, with each partner set to hold a 50% stake. Completion is targeted for the first half of 2027. Clearing antitrust review marks a significant milestone, yet approval is not the same as consummation — until the deal closes, Peranel remains a proposal on paper rather than an operating business.
A Mixed Picture on the Legal Front
Relief and new allegations are arriving side by side. On 9 October, the public prosecutor's office in Épinal dropped criminal proceedings against Nestlé Waters Supply Est after concluding the company had met every obligation under its agreement. That closed chapter stands apart from a new case filed in Texas, where Attorney General Ken Paxton sued Gerber Products Company and Nestlé USA on Wednesday over allegedly misleading claims about the safety of Gerber baby food and purported contamination with arsenic and lead. Those accusations have not been established in court, so the French resolution offers no blanket clearance for the group's wider legal exposure.
Should investors sell immediately? Or is it worth buying Nestle?
JPMorgan Flips to Overweight
Analysts, too, are sending conflicting signals. Bernstein Research on Monday reaffirmed its "Market-Perform" rating and CHF 74 price target, making no change to its assessment. JPMorgan went the other way, upgrading the stock from "Neutral" to "Overweight" — ending a two-and-a-half-year stretch of neutral coverage — on expectations that growth and profitability will revive. Analyst Celine Pannuti sees Nestlé hitting its medium-term targets next year, and combined with a historically low valuation, that opens room for a re-rating in her view.
The upgrade lifted the shares 2.6% on the day, though the investment case rests less on the price move than on an anticipated business improvement. JPMorgan raised its target to CHF 100 from CHF 90, with Pannuti singling out 2027 as a particularly strong year.
Her thesis leans on several operational levers rather than cost cuts alone: a recovery in North America, possible market-share gains in emerging markets, and more favourable raw-material costs. JPMorgan projects like-for-like sales growth of 4.2%, an operating margin above 17%, and real internal growth (RIG) close to 2%. That mix matters — the bank expects both firmer demand and stable pricing, so the forecast expansion would not rest solely on price increases.
Savings, Cash Flow and a Cheap Multiple
Additional support should come from CHF 3 billion in targeted cost savings through 2028, a second pillar alongside the demand recovery. JPMorgan sees the operational upturn feeding through to cash generation, with free cash flow recovering to CHF 10–11 billion and the net debt-to-EBITDA ratio falling to 2.3 next year — easing leverage metrics beyond the top-line and margin gains.
Valuation provides the other half of the argument. Excluding the L'Oréal stake, JPMorgan puts Nestlé at 15 times expected 2027 earnings, close to its lowest level in 15 years. Pannuti derives the re-rating opportunity from that discount, though the market would have to grant a higher multiple for it to materialise — making the expected recovery a precondition rather than a given.
Nestle at a turning point? This analysis reveals what investors need to know now.
Notably, JPMorgan trimmed its earnings-per-share forecast for next year by 1%, even as that figure sits 1% above consensus. Adjusted EPS growth is put at roughly 6%. The upgrade, then, does not rest on a raised profit estimate; it pairs an anticipated operational rebound with what the bank regards as an attractive valuation. For shareholders, the re-rating potential hinges on whether Nestlé delivers on growth, margin and cash flow as promised.
October 22 Is the Next Test
The near-term focal point is 22 October, when Nestlé reports third-quarter 2026 figures. That will shift attention from regulatory and legal headlines back to the underlying business. The question for investors is not simply whether the winning streak continues, but what operating results Nestlé can set against the friendlier share price. The water venture's clearance is progress — it substitutes neither for the deal's completion nor for the earnings update still to come.
Ad
Nestle Stock: New Analysis - 16 October
Fresh Nestle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
